FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flawsnews2024-05-31T19:08:30+00:00May 31st, 2024|The New York Times|
Ozempic May Help Treat Kidney Disease, Study Findsnews2024-05-24T10:35:06+00:00May 24th, 2024|The New York Times|
Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’snews2024-05-06T16:19:15+00:00May 6th, 2024|The New York Times|
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugsnews2024-04-15T19:47:14+00:00April 15th, 2024|The New York Times|
Un estudiomostró que se puede frenar el párkinson con lixisenatidanews2024-04-05T16:59:42+00:00April 5th, 2024|The New York Times|
An Ozempic Relative Slowed Parkinson’s Disease in a Small Studynews2024-04-03T21:02:24+00:00April 3rd, 2024|The New York Times|
Lo que hay que saber sobre la ibogaínanews2024-03-09T10:02:51+00:00March 9th, 2024|The New York Times|
¿Se puede tener alzhéimer y no presentar síntomas?news2024-03-06T15:35:15+00:00March 6th, 2024|The New York Times|
Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
